PDE Inhibitors Market - Global Outlook and Forecast 2022-2028
This report contains market size and forecasts of Yacht Engine in global, including the following market information:
Global Yacht Engine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Yacht Engine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Yacht Engine companies in 2021 (%)
The global Yacht Engine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Installation Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Yacht Engine include MTU, Caterpillar, MAN SE, Cummins, Volvo Penta, SCANIA, Mase Generator, Nanni Industries and Onan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Yacht Engine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Yacht Engine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Yacht Engine Market Segment Percentages, by Type, 2021 (%)
Global Yacht Engine Market Segment Percentages, by Application, 2021 (%)
Global Yacht Engine Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Yacht Engine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Yacht Engine revenues share in global market, 2021 (%)
Key companies Yacht Engine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Yacht Engine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Global Yacht Engine Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global Yacht Engine Market Sales, 2017-2022, 2023-2028, (K Units)
Global top five Yacht Engine companies in 2021 (%)
The global Yacht Engine market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
by Installation Type Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Yacht Engine include MTU, Caterpillar, MAN SE, Cummins, Volvo Penta, SCANIA, Mase Generator, Nanni Industries and Onan, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Yacht Engine manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Yacht Engine Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)
Global Yacht Engine Market Segment Percentages, by Type, 2021 (%)
- by Installation Type
- Inboard Machine
- Side Inside And Outside The Machine
- Outboard Engine
- Jet Engine
- by Power
- 250KW to 600 KW
- 601KW to1200KW
- 1201KW to 3000KW
- 3001kW to 7000KW
- Above 7000KW
- by Fuel
- Gasoline Engine
- Diesel Engine
Global Yacht Engine Market Segment Percentages, by Application, 2021 (%)
- General Yacht
- Displacement Yacht
- Performance Yacht
- Others
Global Yacht Engine Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Yacht Engine revenues in global market, 2017-2022 (Estimated), ($ millions)
Key companies Yacht Engine revenues share in global market, 2021 (%)
Key companies Yacht Engine sales in global market, 2017-2022 (Estimated), (K Units)
Key companies Yacht Engine sales share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- MTU
- Caterpillar
- MAN SE
- Cummins
- Volvo Penta
- SCANIA
- Mase Generator
- Nanni Industries
- Onan
- Fischer Panda
- WhisperPower
- Westerbeke
- Lombardini Marine
- Sole Diesel
- Northern Lights
- COELMO MARINE
- VETUS
- Mercury Marine
- Yamaha
- Yanmar
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 PDE Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PDE Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PDE INHIBITORS OVERALL MARKET SIZE
2.1 Global PDE Inhibitors Market Size: 2021 VS 2028
2.2 Global PDE Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PDE Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PDE Inhibitors Players in Global Market
3.2 Top Global PDE Inhibitors Companies Ranked by Revenue
3.3 Global PDE Inhibitors Revenue by Companies
3.4 Global PDE Inhibitors Sales by Companies
3.5 Global PDE Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PDE Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PDE Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 PDE Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 PDE Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 PDE Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PDE Inhibitors Market Size Markets, 2021 & 2028
4.1.2 PDE5
4.1.3 PDE4
4.1.4 Viagra
4.1.5 Cialis
4.1.6 Levitra
4.1.7 Others
4.2 By Type - Global PDE Inhibitors Revenue & Forecasts
4.2.1 By Type - Global PDE Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global PDE Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global PDE Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global PDE Inhibitors Sales & Forecasts
4.3.1 By Type - Global PDE Inhibitors Sales, 2017-2022
4.3.2 By Type - Global PDE Inhibitors Sales, 2023-2028
4.3.3 By Type - Global PDE Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global PDE Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PDE Inhibitors Market Size, 2021 & 2028
5.1.2 Genitourinary
5.1.3 Cardiovascular Diseases
5.1.4 Dermatological Disorders
5.1.5 Respiratory Diseases
5.1.6 Schizophrenia
5.1.7 Alzheimer’S Disease
5.1.8 Huntington’S Disease
5.1.9 Others
5.2 By Application - Global PDE Inhibitors Revenue & Forecasts
5.2.1 By Application - Global PDE Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global PDE Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global PDE Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global PDE Inhibitors Sales & Forecasts
5.3.1 By Application - Global PDE Inhibitors Sales, 2017-2022
5.3.2 By Application - Global PDE Inhibitors Sales, 2023-2028
5.3.3 By Application - Global PDE Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global PDE Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PDE Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global PDE Inhibitors Revenue & Forecasts
6.2.1 By Region - Global PDE Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global PDE Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global PDE Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global PDE Inhibitors Sales & Forecasts
6.3.1 By Region - Global PDE Inhibitors Sales, 2017-2022
6.3.2 By Region - Global PDE Inhibitors Sales, 2023-2028
6.3.3 By Region - Global PDE Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PDE Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America PDE Inhibitors Sales, 2017-2028
6.4.3 US PDE Inhibitors Market Size, 2017-2028
6.4.4 Canada PDE Inhibitors Market Size, 2017-2028
6.4.5 Mexico PDE Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PDE Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe PDE Inhibitors Sales, 2017-2028
6.5.3 Germany PDE Inhibitors Market Size, 2017-2028
6.5.4 France PDE Inhibitors Market Size, 2017-2028
6.5.5 U.K. PDE Inhibitors Market Size, 2017-2028
6.5.6 Italy PDE Inhibitors Market Size, 2017-2028
6.5.7 Russia PDE Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries PDE Inhibitors Market Size, 2017-2028
6.5.9 Benelux PDE Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PDE Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia PDE Inhibitors Sales, 2017-2028
6.6.3 China PDE Inhibitors Market Size, 2017-2028
6.6.4 Japan PDE Inhibitors Market Size, 2017-2028
6.6.5 South Korea PDE Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia PDE Inhibitors Market Size, 2017-2028
6.6.7 India PDE Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PDE Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America PDE Inhibitors Sales, 2017-2028
6.7.3 Brazil PDE Inhibitors Market Size, 2017-2028
6.7.4 Argentina PDE Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PDE Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PDE Inhibitors Sales, 2017-2028
6.8.3 Turkey PDE Inhibitors Market Size, 2017-2028
6.8.4 Israel PDE Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia PDE Inhibitors Market Size, 2017-2028
6.8.6 UAE PDE Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Hanmi Science Holding
7.1.1 Hanmi Science Holding Corporate Summary
7.1.2 Hanmi Science Holding Business Overview
7.1.3 Hanmi Science Holding PDE Inhibitors Major Product Offerings
7.1.4 Hanmi Science Holding PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Hanmi Science Holding Key News
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Corporate Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim PDE Inhibitors Major Product Offerings
7.2.4 Boehringer Ingelheim PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Boehringer Ingelheim Key News
7.3 Takeda Pharmaceuticals
7.3.1 Takeda Pharmaceuticals Corporate Summary
7.3.2 Takeda Pharmaceuticals Business Overview
7.3.3 Takeda Pharmaceuticals PDE Inhibitors Major Product Offerings
7.3.4 Takeda Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Takeda Pharmaceuticals Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca PDE Inhibitors Major Product Offerings
7.4.4 AstraZeneca PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer PDE Inhibitors Major Product Offerings
7.5.4 Bayer PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene PDE Inhibitors Major Product Offerings
7.6.4 Celgene PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Celgene Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly PDE Inhibitors Major Product Offerings
7.7.4 Eli Lilly PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer PDE Inhibitors Major Product Offerings
7.8.4 Pfizer PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 BioCrea
7.9.1 BioCrea Corporate Summary
7.9.2 BioCrea Business Overview
7.9.3 BioCrea PDE Inhibitors Major Product Offerings
7.9.4 BioCrea PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.9.5 BioCrea Key News
7.10 Dart NeuroScience
7.10.1 Dart NeuroScience Corporate Summary
7.10.2 Dart NeuroScience Business Overview
7.10.3 Dart NeuroScience PDE Inhibitors Major Product Offerings
7.10.4 Dart NeuroScience PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.10.5 Dart NeuroScience Key News
7.11 Carinopharm
7.11.1 Carinopharm Corporate Summary
7.11.2 Carinopharm PDE Inhibitors Business Overview
7.11.3 Carinopharm PDE Inhibitors Major Product Offerings
7.11.4 Carinopharm PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.11.5 Carinopharm Key News
7.12 CTC Bio
7.12.1 CTC Bio Corporate Summary
7.12.2 CTC Bio PDE Inhibitors Business Overview
7.12.3 CTC Bio PDE Inhibitors Major Product Offerings
7.12.4 CTC Bio PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.12.5 CTC Bio Key News
7.13 FORUM Pharmaceuticals
7.13.1 FORUM Pharmaceuticals Corporate Summary
7.13.2 FORUM Pharmaceuticals PDE Inhibitors Business Overview
7.13.3 FORUM Pharmaceuticals PDE Inhibitors Major Product Offerings
7.13.4 FORUM Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.13.5 FORUM Pharmaceuticals Key News
7.14 Intra-Cellular Therapies
7.14.1 Intra-Cellular Therapies Corporate Summary
7.14.2 Intra-Cellular Therapies Business Overview
7.14.3 Intra-Cellular Therapies PDE Inhibitors Major Product Offerings
7.14.4 Intra-Cellular Therapies PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.14.5 Intra-Cellular Therapies Key News
7.15 Omeros Corporation
7.15.1 Omeros Corporation Corporate Summary
7.15.2 Omeros Corporation Business Overview
7.15.3 Omeros Corporation PDE Inhibitors Major Product Offerings
7.15.4 Omeros Corporation PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.15.5 Omeros Corporation Key News
7.16 Medimetriks Pharmaceuticals
7.16.1 Medimetriks Pharmaceuticals Corporate Summary
7.16.2 Medimetriks Pharmaceuticals Business Overview
7.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Major Product Offerings
7.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.16.5 Medimetriks Pharmaceuticals Key News
7.17 NuSirt Biopharma
7.17.1 NuSirt Biopharma Corporate Summary
7.17.2 NuSirt Biopharma Business Overview
7.17.3 NuSirt Biopharma PDE Inhibitors Major Product Offerings
7.17.4 NuSirt Biopharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.17.5 NuSirt Biopharma Key News
7.18 Palobiopharma
7.18.1 Palobiopharma Corporate Summary
7.18.2 Palobiopharma Business Overview
7.18.3 Palobiopharma PDE Inhibitors Major Product Offerings
7.18.4 Palobiopharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.18.5 Palobiopharma Key News
7.19 Roivant Sciences
7.19.1 Roivant Sciences Corporate Summary
7.19.2 Roivant Sciences Business Overview
7.19.3 Roivant Sciences PDE Inhibitors Major Product Offerings
7.19.4 Roivant Sciences PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.19.5 Roivant Sciences Key News
7.20 Sagene Pharmaceuticals
7.20.1 Sagene Pharmaceuticals Corporate Summary
7.20.2 Sagene Pharmaceuticals Business Overview
7.20.3 Sagene Pharmaceuticals PDE Inhibitors Major Product Offerings
7.20.4 Sagene Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.20.5 Sagene Pharmaceuticals Key News
7.21 Tetra Discovery Partners
7.21.1 Tetra Discovery Partners Corporate Summary
7.21.2 Tetra Discovery Partners Business Overview
7.21.3 Tetra Discovery Partners PDE Inhibitors Major Product Offerings
7.21.4 Tetra Discovery Partners PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.21.5 Tetra Discovery Partners Key News
7.22 Tritech Biopharm
7.22.1 Tritech Biopharm Corporate Summary
7.22.2 Tritech Biopharm Business Overview
7.22.3 Tritech Biopharm PDE Inhibitors Major Product Offerings
7.22.4 Tritech Biopharm PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.22.5 Tritech Biopharm Key News
7.23 Otsuka
7.23.1 Otsuka Corporate Summary
7.23.2 Otsuka Business Overview
7.23.3 Otsuka PDE Inhibitors Major Product Offerings
7.23.4 Otsuka PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.23.5 Otsuka Key News
7.24 Chiesi Farmaceutici
7.24.1 Chiesi Farmaceutici Corporate Summary
7.24.2 Chiesi Farmaceutici Business Overview
7.24.3 Chiesi Farmaceutici PDE Inhibitors Major Product Offerings
7.24.4 Chiesi Farmaceutici PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.24.5 Chiesi Farmaceutici Key News
7.25 Verona Pharma
7.25.1 Verona Pharma Corporate Summary
7.25.2 Verona Pharma Business Overview
7.25.3 Verona Pharma PDE Inhibitors Major Product Offerings
7.25.4 Verona Pharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.25.5 Verona Pharma Key News
8 GLOBAL PDE INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global PDE Inhibitors Production Capacity, 2017-2028
8.2 PDE Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global PDE Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PDE INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 PDE Inhibitors Industry Value Chain
10.2 PDE Inhibitors Upstream Market
10.3 PDE Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PDE Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
1.1 PDE Inhibitors Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global PDE Inhibitors Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL PDE INHIBITORS OVERALL MARKET SIZE
2.1 Global PDE Inhibitors Market Size: 2021 VS 2028
2.2 Global PDE Inhibitors Revenue, Prospects & Forecasts: 2017-2028
2.3 Global PDE Inhibitors Sales: 2017-2028
3 COMPANY LANDSCAPE
3.1 Top PDE Inhibitors Players in Global Market
3.2 Top Global PDE Inhibitors Companies Ranked by Revenue
3.3 Global PDE Inhibitors Revenue by Companies
3.4 Global PDE Inhibitors Sales by Companies
3.5 Global PDE Inhibitors Price by Manufacturer (2017-2022)
3.6 Top 3 and Top 5 PDE Inhibitors Companies in Global Market, by Revenue in 2021
3.7 Global Manufacturers PDE Inhibitors Product Type
3.8 Tier 1, Tier 2 and Tier 3 PDE Inhibitors Players in Global Market
3.8.1 List of Global Tier 1 PDE Inhibitors Companies
3.8.2 List of Global Tier 2 and Tier 3 PDE Inhibitors Companies
4 SIGHTS BY PRODUCT
4.1 Overview
4.1.1 By Type - Global PDE Inhibitors Market Size Markets, 2021 & 2028
4.1.2 PDE5
4.1.3 PDE4
4.1.4 Viagra
4.1.5 Cialis
4.1.6 Levitra
4.1.7 Others
4.2 By Type - Global PDE Inhibitors Revenue & Forecasts
4.2.1 By Type - Global PDE Inhibitors Revenue, 2017-2022
4.2.2 By Type - Global PDE Inhibitors Revenue, 2023-2028
4.2.3 By Type - Global PDE Inhibitors Revenue Market Share, 2017-2028
4.3 By Type - Global PDE Inhibitors Sales & Forecasts
4.3.1 By Type - Global PDE Inhibitors Sales, 2017-2022
4.3.2 By Type - Global PDE Inhibitors Sales, 2023-2028
4.3.3 By Type - Global PDE Inhibitors Sales Market Share, 2017-2028
4.4 By Type - Global PDE Inhibitors Price (Manufacturers Selling Prices), 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global PDE Inhibitors Market Size, 2021 & 2028
5.1.2 Genitourinary
5.1.3 Cardiovascular Diseases
5.1.4 Dermatological Disorders
5.1.5 Respiratory Diseases
5.1.6 Schizophrenia
5.1.7 Alzheimer’S Disease
5.1.8 Huntington’S Disease
5.1.9 Others
5.2 By Application - Global PDE Inhibitors Revenue & Forecasts
5.2.1 By Application - Global PDE Inhibitors Revenue, 2017-2022
5.2.2 By Application - Global PDE Inhibitors Revenue, 2023-2028
5.2.3 By Application - Global PDE Inhibitors Revenue Market Share, 2017-2028
5.3 By Application - Global PDE Inhibitors Sales & Forecasts
5.3.1 By Application - Global PDE Inhibitors Sales, 2017-2022
5.3.2 By Application - Global PDE Inhibitors Sales, 2023-2028
5.3.3 By Application - Global PDE Inhibitors Sales Market Share, 2017-2028
5.4 By Application - Global PDE Inhibitors Price (Manufacturers Selling Prices), 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global PDE Inhibitors Market Size, 2021 & 2028
6.2 By Region - Global PDE Inhibitors Revenue & Forecasts
6.2.1 By Region - Global PDE Inhibitors Revenue, 2017-2022
6.2.2 By Region - Global PDE Inhibitors Revenue, 2023-2028
6.2.3 By Region - Global PDE Inhibitors Revenue Market Share, 2017-2028
6.3 By Region - Global PDE Inhibitors Sales & Forecasts
6.3.1 By Region - Global PDE Inhibitors Sales, 2017-2022
6.3.2 By Region - Global PDE Inhibitors Sales, 2023-2028
6.3.3 By Region - Global PDE Inhibitors Sales Market Share, 2017-2028
6.4 North America
6.4.1 By Country - North America PDE Inhibitors Revenue, 2017-2028
6.4.2 By Country - North America PDE Inhibitors Sales, 2017-2028
6.4.3 US PDE Inhibitors Market Size, 2017-2028
6.4.4 Canada PDE Inhibitors Market Size, 2017-2028
6.4.5 Mexico PDE Inhibitors Market Size, 2017-2028
6.5 Europe
6.5.1 By Country - Europe PDE Inhibitors Revenue, 2017-2028
6.5.2 By Country - Europe PDE Inhibitors Sales, 2017-2028
6.5.3 Germany PDE Inhibitors Market Size, 2017-2028
6.5.4 France PDE Inhibitors Market Size, 2017-2028
6.5.5 U.K. PDE Inhibitors Market Size, 2017-2028
6.5.6 Italy PDE Inhibitors Market Size, 2017-2028
6.5.7 Russia PDE Inhibitors Market Size, 2017-2028
6.5.8 Nordic Countries PDE Inhibitors Market Size, 2017-2028
6.5.9 Benelux PDE Inhibitors Market Size, 2017-2028
6.6 Asia
6.6.1 By Region - Asia PDE Inhibitors Revenue, 2017-2028
6.6.2 By Region - Asia PDE Inhibitors Sales, 2017-2028
6.6.3 China PDE Inhibitors Market Size, 2017-2028
6.6.4 Japan PDE Inhibitors Market Size, 2017-2028
6.6.5 South Korea PDE Inhibitors Market Size, 2017-2028
6.6.6 Southeast Asia PDE Inhibitors Market Size, 2017-2028
6.6.7 India PDE Inhibitors Market Size, 2017-2028
6.7 South America
6.7.1 By Country - South America PDE Inhibitors Revenue, 2017-2028
6.7.2 By Country - South America PDE Inhibitors Sales, 2017-2028
6.7.3 Brazil PDE Inhibitors Market Size, 2017-2028
6.7.4 Argentina PDE Inhibitors Market Size, 2017-2028
6.8 Middle East & Africa
6.8.1 By Country - Middle East & Africa PDE Inhibitors Revenue, 2017-2028
6.8.2 By Country - Middle East & Africa PDE Inhibitors Sales, 2017-2028
6.8.3 Turkey PDE Inhibitors Market Size, 2017-2028
6.8.4 Israel PDE Inhibitors Market Size, 2017-2028
6.8.5 Saudi Arabia PDE Inhibitors Market Size, 2017-2028
6.8.6 UAE PDE Inhibitors Market Size, 2017-2028
7 MANUFACTURERS & BRANDS PROFILES
7.1 Hanmi Science Holding
7.1.1 Hanmi Science Holding Corporate Summary
7.1.2 Hanmi Science Holding Business Overview
7.1.3 Hanmi Science Holding PDE Inhibitors Major Product Offerings
7.1.4 Hanmi Science Holding PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.1.5 Hanmi Science Holding Key News
7.2 Boehringer Ingelheim
7.2.1 Boehringer Ingelheim Corporate Summary
7.2.2 Boehringer Ingelheim Business Overview
7.2.3 Boehringer Ingelheim PDE Inhibitors Major Product Offerings
7.2.4 Boehringer Ingelheim PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.2.5 Boehringer Ingelheim Key News
7.3 Takeda Pharmaceuticals
7.3.1 Takeda Pharmaceuticals Corporate Summary
7.3.2 Takeda Pharmaceuticals Business Overview
7.3.3 Takeda Pharmaceuticals PDE Inhibitors Major Product Offerings
7.3.4 Takeda Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.3.5 Takeda Pharmaceuticals Key News
7.4 AstraZeneca
7.4.1 AstraZeneca Corporate Summary
7.4.2 AstraZeneca Business Overview
7.4.3 AstraZeneca PDE Inhibitors Major Product Offerings
7.4.4 AstraZeneca PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.4.5 AstraZeneca Key News
7.5 Bayer
7.5.1 Bayer Corporate Summary
7.5.2 Bayer Business Overview
7.5.3 Bayer PDE Inhibitors Major Product Offerings
7.5.4 Bayer PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.5.5 Bayer Key News
7.6 Celgene
7.6.1 Celgene Corporate Summary
7.6.2 Celgene Business Overview
7.6.3 Celgene PDE Inhibitors Major Product Offerings
7.6.4 Celgene PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.6.5 Celgene Key News
7.7 Eli Lilly
7.7.1 Eli Lilly Corporate Summary
7.7.2 Eli Lilly Business Overview
7.7.3 Eli Lilly PDE Inhibitors Major Product Offerings
7.7.4 Eli Lilly PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.7.5 Eli Lilly Key News
7.8 Pfizer
7.8.1 Pfizer Corporate Summary
7.8.2 Pfizer Business Overview
7.8.3 Pfizer PDE Inhibitors Major Product Offerings
7.8.4 Pfizer PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.8.5 Pfizer Key News
7.9 BioCrea
7.9.1 BioCrea Corporate Summary
7.9.2 BioCrea Business Overview
7.9.3 BioCrea PDE Inhibitors Major Product Offerings
7.9.4 BioCrea PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.9.5 BioCrea Key News
7.10 Dart NeuroScience
7.10.1 Dart NeuroScience Corporate Summary
7.10.2 Dart NeuroScience Business Overview
7.10.3 Dart NeuroScience PDE Inhibitors Major Product Offerings
7.10.4 Dart NeuroScience PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.10.5 Dart NeuroScience Key News
7.11 Carinopharm
7.11.1 Carinopharm Corporate Summary
7.11.2 Carinopharm PDE Inhibitors Business Overview
7.11.3 Carinopharm PDE Inhibitors Major Product Offerings
7.11.4 Carinopharm PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.11.5 Carinopharm Key News
7.12 CTC Bio
7.12.1 CTC Bio Corporate Summary
7.12.2 CTC Bio PDE Inhibitors Business Overview
7.12.3 CTC Bio PDE Inhibitors Major Product Offerings
7.12.4 CTC Bio PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.12.5 CTC Bio Key News
7.13 FORUM Pharmaceuticals
7.13.1 FORUM Pharmaceuticals Corporate Summary
7.13.2 FORUM Pharmaceuticals PDE Inhibitors Business Overview
7.13.3 FORUM Pharmaceuticals PDE Inhibitors Major Product Offerings
7.13.4 FORUM Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.13.5 FORUM Pharmaceuticals Key News
7.14 Intra-Cellular Therapies
7.14.1 Intra-Cellular Therapies Corporate Summary
7.14.2 Intra-Cellular Therapies Business Overview
7.14.3 Intra-Cellular Therapies PDE Inhibitors Major Product Offerings
7.14.4 Intra-Cellular Therapies PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.14.5 Intra-Cellular Therapies Key News
7.15 Omeros Corporation
7.15.1 Omeros Corporation Corporate Summary
7.15.2 Omeros Corporation Business Overview
7.15.3 Omeros Corporation PDE Inhibitors Major Product Offerings
7.15.4 Omeros Corporation PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.15.5 Omeros Corporation Key News
7.16 Medimetriks Pharmaceuticals
7.16.1 Medimetriks Pharmaceuticals Corporate Summary
7.16.2 Medimetriks Pharmaceuticals Business Overview
7.16.3 Medimetriks Pharmaceuticals PDE Inhibitors Major Product Offerings
7.16.4 Medimetriks Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.16.5 Medimetriks Pharmaceuticals Key News
7.17 NuSirt Biopharma
7.17.1 NuSirt Biopharma Corporate Summary
7.17.2 NuSirt Biopharma Business Overview
7.17.3 NuSirt Biopharma PDE Inhibitors Major Product Offerings
7.17.4 NuSirt Biopharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.17.5 NuSirt Biopharma Key News
7.18 Palobiopharma
7.18.1 Palobiopharma Corporate Summary
7.18.2 Palobiopharma Business Overview
7.18.3 Palobiopharma PDE Inhibitors Major Product Offerings
7.18.4 Palobiopharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.18.5 Palobiopharma Key News
7.19 Roivant Sciences
7.19.1 Roivant Sciences Corporate Summary
7.19.2 Roivant Sciences Business Overview
7.19.3 Roivant Sciences PDE Inhibitors Major Product Offerings
7.19.4 Roivant Sciences PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.19.5 Roivant Sciences Key News
7.20 Sagene Pharmaceuticals
7.20.1 Sagene Pharmaceuticals Corporate Summary
7.20.2 Sagene Pharmaceuticals Business Overview
7.20.3 Sagene Pharmaceuticals PDE Inhibitors Major Product Offerings
7.20.4 Sagene Pharmaceuticals PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.20.5 Sagene Pharmaceuticals Key News
7.21 Tetra Discovery Partners
7.21.1 Tetra Discovery Partners Corporate Summary
7.21.2 Tetra Discovery Partners Business Overview
7.21.3 Tetra Discovery Partners PDE Inhibitors Major Product Offerings
7.21.4 Tetra Discovery Partners PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.21.5 Tetra Discovery Partners Key News
7.22 Tritech Biopharm
7.22.1 Tritech Biopharm Corporate Summary
7.22.2 Tritech Biopharm Business Overview
7.22.3 Tritech Biopharm PDE Inhibitors Major Product Offerings
7.22.4 Tritech Biopharm PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.22.5 Tritech Biopharm Key News
7.23 Otsuka
7.23.1 Otsuka Corporate Summary
7.23.2 Otsuka Business Overview
7.23.3 Otsuka PDE Inhibitors Major Product Offerings
7.23.4 Otsuka PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.23.5 Otsuka Key News
7.24 Chiesi Farmaceutici
7.24.1 Chiesi Farmaceutici Corporate Summary
7.24.2 Chiesi Farmaceutici Business Overview
7.24.3 Chiesi Farmaceutici PDE Inhibitors Major Product Offerings
7.24.4 Chiesi Farmaceutici PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.24.5 Chiesi Farmaceutici Key News
7.25 Verona Pharma
7.25.1 Verona Pharma Corporate Summary
7.25.2 Verona Pharma Business Overview
7.25.3 Verona Pharma PDE Inhibitors Major Product Offerings
7.25.4 Verona Pharma PDE Inhibitors Sales and Revenue in Global (2017-2022)
7.25.5 Verona Pharma Key News
8 GLOBAL PDE INHIBITORS PRODUCTION CAPACITY, ANALYSIS
8.1 Global PDE Inhibitors Production Capacity, 2017-2028
8.2 PDE Inhibitors Production Capacity of Key Manufacturers in Global Market
8.3 Global PDE Inhibitors Production by Region
9 KEY MARKET TRENDS, OPPORTUNITY, DRIVERS AND RESTRAINTS
9.1 Market Opportunities & Trends
9.2 Market Drivers
9.3 Market Restraints
10 PDE INHIBITORS SUPPLY CHAIN ANALYSIS
10.1 PDE Inhibitors Industry Value Chain
10.2 PDE Inhibitors Upstream Market
10.3 PDE Inhibitors Downstream and Clients
10.4 Marketing Channels Analysis
10.4.1 Marketing Channels
10.4.2 PDE Inhibitors Distributors and Sales Agents in Global
11 CONCLUSION
12 APPENDIX
12.1 Note
12.2 Examples of Clients
12.3 Disclaimer
LIST OF TABLES
Table 1. Key Players of PDE Inhibitors in Global Market
Table 2. Top PDE Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PDE Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PDE Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global PDE Inhibitors Sales by Companies, (K Units), 2017-2022
Table 6. Global PDE Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PDE Inhibitors Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers PDE Inhibitors Product Type
Table 9. List of Global Tier 1 PDE Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PDE Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PDE Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 15. By Type - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 16. By Application – Global PDE Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 20. By Application - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 21. By Region – Global PDE Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 25. By Region - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 26. By Country - North America PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PDE Inhibitors Sales, (K Units), 2017-2022
Table 29. By Country - North America PDE Inhibitors Sales, (K Units), 2023-2028
Table 30. By Country - Europe PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PDE Inhibitors Sales, (K Units), 2017-2022
Table 33. By Country - Europe PDE Inhibitors Sales, (K Units), 2023-2028
Table 34. By Region - Asia PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PDE Inhibitors Sales, (K Units), 2017-2022
Table 37. By Region - Asia PDE Inhibitors Sales, (K Units), 2023-2028
Table 38. By Country - South America PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PDE Inhibitors Sales, (K Units), 2017-2022
Table 41. By Country - South America PDE Inhibitors Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PDE Inhibitors Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa PDE Inhibitors Sales, (K Units), 2023-2028
Table 46. Hanmi Science Holding Corporate Summary
Table 47. Hanmi Science Holding PDE Inhibitors Product Offerings
Table 48. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Boehringer Ingelheim Corporate Summary
Table 50. Boehringer Ingelheim PDE Inhibitors Product Offerings
Table 51. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Takeda Pharmaceuticals Corporate Summary
Table 53. Takeda Pharmaceuticals PDE Inhibitors Product Offerings
Table 54. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. AstraZeneca Corporate Summary
Table 56. AstraZeneca PDE Inhibitors Product Offerings
Table 57. AstraZeneca PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer PDE Inhibitors Product Offerings
Table 60. Bayer PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Celgene Corporate Summary
Table 62. Celgene PDE Inhibitors Product Offerings
Table 63. Celgene PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly PDE Inhibitors Product Offerings
Table 66. Eli Lilly PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer PDE Inhibitors Product Offerings
Table 69. Pfizer PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. BioCrea Corporate Summary
Table 71. BioCrea PDE Inhibitors Product Offerings
Table 72. BioCrea PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Dart NeuroScience Corporate Summary
Table 74. Dart NeuroScience PDE Inhibitors Product Offerings
Table 75. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Carinopharm Corporate Summary
Table 77. Carinopharm PDE Inhibitors Product Offerings
Table 78. Carinopharm PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. CTC Bio Corporate Summary
Table 80. CTC Bio PDE Inhibitors Product Offerings
Table 81. CTC Bio PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. FORUM Pharmaceuticals Corporate Summary
Table 83. FORUM Pharmaceuticals PDE Inhibitors Product Offerings
Table 84. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Intra-Cellular Therapies Corporate Summary
Table 86. Intra-Cellular Therapies PDE Inhibitors Product Offerings
Table 87. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Omeros Corporation Corporate Summary
Table 89. Omeros Corporation PDE Inhibitors Product Offerings
Table 90. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Medimetriks Pharmaceuticals Corporate Summary
Table 92. Medimetriks Pharmaceuticals PDE Inhibitors Product Offerings
Table 93. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. NuSirt Biopharma Corporate Summary
Table 95. NuSirt Biopharma PDE Inhibitors Product Offerings
Table 96. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Palobiopharma Corporate Summary
Table 98. Palobiopharma PDE Inhibitors Product Offerings
Table 99. Palobiopharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Roivant Sciences Corporate Summary
Table 101. Roivant Sciences PDE Inhibitors Product Offerings
Table 102. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Sagene Pharmaceuticals Corporate Summary
Table 104. Sagene Pharmaceuticals PDE Inhibitors Product Offerings
Table 105. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Tetra Discovery Partners Corporate Summary
Table 107. Tetra Discovery Partners PDE Inhibitors Product Offerings
Table 108. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Tritech Biopharm Corporate Summary
Table 110. Tritech Biopharm PDE Inhibitors Product Offerings
Table 111. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Otsuka Corporate Summary
Table 113. Otsuka PDE Inhibitors Product Offerings
Table 114. Otsuka PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Chiesi Farmaceutici Corporate Summary
Table 116. Chiesi Farmaceutici PDE Inhibitors Product Offerings
Table 117. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 118. Verona Pharma Corporate Summary
Table 119. Verona Pharma PDE Inhibitors Product Offerings
Table 120. Verona Pharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 121. PDE Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 122. Global PDE Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 123. Global PDE Inhibitors Production by Region, 2017-2022 (K Units)
Table 124. Global PDE Inhibitors Production by Region, 2023-2028 (K Units)
Table 125. PDE Inhibitors Market Opportunities & Trends in Global Market
Table 126. PDE Inhibitors Market Drivers in Global Market
Table 127. PDE Inhibitors Market Restraints in Global Market
Table 128. PDE Inhibitors Raw Materials
Table 129. PDE Inhibitors Raw Materials Suppliers in Global Market
Table 130. Typical PDE Inhibitors Downstream
Table 131. PDE Inhibitors Downstream Clients in Global Market
Table 132. PDE Inhibitors Distributors and Sales Agents in Global Market
Table 1. Key Players of PDE Inhibitors in Global Market
Table 2. Top PDE Inhibitors Players in Global Market, Ranking by Revenue (2021)
Table 3. Global PDE Inhibitors Revenue by Companies, (US$, Mn), 2017-2022
Table 4. Global PDE Inhibitors Revenue Share by Companies, 2017-2022
Table 5. Global PDE Inhibitors Sales by Companies, (K Units), 2017-2022
Table 6. Global PDE Inhibitors Sales Share by Companies, 2017-2022
Table 7. Key Manufacturers PDE Inhibitors Price (2017-2022) & (USD/Unit)
Table 8. Global Manufacturers PDE Inhibitors Product Type
Table 9. List of Global Tier 1 PDE Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 PDE Inhibitors Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global PDE Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 13. By Type - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 14. By Type - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 15. By Type - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 16. By Application – Global PDE Inhibitors Revenue, (US$, Mn), 2021 & 2028
Table 17. By Application - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 18. By Application - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 19. By Application - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 20. By Application - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 21. By Region – Global PDE Inhibitors Revenue, (US$, Mn), 2021 VS 2028
Table 22. By Region - Global PDE Inhibitors Revenue (US$, Mn), 2017-2022
Table 23. By Region - Global PDE Inhibitors Revenue (US$, Mn), 2023-2028
Table 24. By Region - Global PDE Inhibitors Sales (K Units), 2017-2022
Table 25. By Region - Global PDE Inhibitors Sales (K Units), 2023-2028
Table 26. By Country - North America PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 27. By Country - North America PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 28. By Country - North America PDE Inhibitors Sales, (K Units), 2017-2022
Table 29. By Country - North America PDE Inhibitors Sales, (K Units), 2023-2028
Table 30. By Country - Europe PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 31. By Country - Europe PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 32. By Country - Europe PDE Inhibitors Sales, (K Units), 2017-2022
Table 33. By Country - Europe PDE Inhibitors Sales, (K Units), 2023-2028
Table 34. By Region - Asia PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 35. By Region - Asia PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 36. By Region - Asia PDE Inhibitors Sales, (K Units), 2017-2022
Table 37. By Region - Asia PDE Inhibitors Sales, (K Units), 2023-2028
Table 38. By Country - South America PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 39. By Country - South America PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 40. By Country - South America PDE Inhibitors Sales, (K Units), 2017-2022
Table 41. By Country - South America PDE Inhibitors Sales, (K Units), 2023-2028
Table 42. By Country - Middle East & Africa PDE Inhibitors Revenue, (US$, Mn), 2017-2022
Table 43. By Country - Middle East & Africa PDE Inhibitors Revenue, (US$, Mn), 2023-2028
Table 44. By Country - Middle East & Africa PDE Inhibitors Sales, (K Units), 2017-2022
Table 45. By Country - Middle East & Africa PDE Inhibitors Sales, (K Units), 2023-2028
Table 46. Hanmi Science Holding Corporate Summary
Table 47. Hanmi Science Holding PDE Inhibitors Product Offerings
Table 48. Hanmi Science Holding PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 49. Boehringer Ingelheim Corporate Summary
Table 50. Boehringer Ingelheim PDE Inhibitors Product Offerings
Table 51. Boehringer Ingelheim PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 52. Takeda Pharmaceuticals Corporate Summary
Table 53. Takeda Pharmaceuticals PDE Inhibitors Product Offerings
Table 54. Takeda Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 55. AstraZeneca Corporate Summary
Table 56. AstraZeneca PDE Inhibitors Product Offerings
Table 57. AstraZeneca PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 58. Bayer Corporate Summary
Table 59. Bayer PDE Inhibitors Product Offerings
Table 60. Bayer PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 61. Celgene Corporate Summary
Table 62. Celgene PDE Inhibitors Product Offerings
Table 63. Celgene PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 64. Eli Lilly Corporate Summary
Table 65. Eli Lilly PDE Inhibitors Product Offerings
Table 66. Eli Lilly PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 67. Pfizer Corporate Summary
Table 68. Pfizer PDE Inhibitors Product Offerings
Table 69. Pfizer PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 70. BioCrea Corporate Summary
Table 71. BioCrea PDE Inhibitors Product Offerings
Table 72. BioCrea PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 73. Dart NeuroScience Corporate Summary
Table 74. Dart NeuroScience PDE Inhibitors Product Offerings
Table 75. Dart NeuroScience PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 76. Carinopharm Corporate Summary
Table 77. Carinopharm PDE Inhibitors Product Offerings
Table 78. Carinopharm PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 79. CTC Bio Corporate Summary
Table 80. CTC Bio PDE Inhibitors Product Offerings
Table 81. CTC Bio PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 82. FORUM Pharmaceuticals Corporate Summary
Table 83. FORUM Pharmaceuticals PDE Inhibitors Product Offerings
Table 84. FORUM Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 85. Intra-Cellular Therapies Corporate Summary
Table 86. Intra-Cellular Therapies PDE Inhibitors Product Offerings
Table 87. Intra-Cellular Therapies PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 88. Omeros Corporation Corporate Summary
Table 89. Omeros Corporation PDE Inhibitors Product Offerings
Table 90. Omeros Corporation PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 91. Medimetriks Pharmaceuticals Corporate Summary
Table 92. Medimetriks Pharmaceuticals PDE Inhibitors Product Offerings
Table 93. Medimetriks Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 94. NuSirt Biopharma Corporate Summary
Table 95. NuSirt Biopharma PDE Inhibitors Product Offerings
Table 96. NuSirt Biopharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 97. Palobiopharma Corporate Summary
Table 98. Palobiopharma PDE Inhibitors Product Offerings
Table 99. Palobiopharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 100. Roivant Sciences Corporate Summary
Table 101. Roivant Sciences PDE Inhibitors Product Offerings
Table 102. Roivant Sciences PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 103. Sagene Pharmaceuticals Corporate Summary
Table 104. Sagene Pharmaceuticals PDE Inhibitors Product Offerings
Table 105. Sagene Pharmaceuticals PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 106. Tetra Discovery Partners Corporate Summary
Table 107. Tetra Discovery Partners PDE Inhibitors Product Offerings
Table 108. Tetra Discovery Partners PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 109. Tritech Biopharm Corporate Summary
Table 110. Tritech Biopharm PDE Inhibitors Product Offerings
Table 111. Tritech Biopharm PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 112. Otsuka Corporate Summary
Table 113. Otsuka PDE Inhibitors Product Offerings
Table 114. Otsuka PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 115. Chiesi Farmaceutici Corporate Summary
Table 116. Chiesi Farmaceutici PDE Inhibitors Product Offerings
Table 117. Chiesi Farmaceutici PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 118. Verona Pharma Corporate Summary
Table 119. Verona Pharma PDE Inhibitors Product Offerings
Table 120. Verona Pharma PDE Inhibitors Sales (K Units), Revenue (US$, Mn) and Average Price (USD/Unit) (2017-2022)
Table 121. PDE Inhibitors Production Capacity (K Units) of Key Manufacturers in Global Market, 2020-2022 (K Units)
Table 122. Global PDE Inhibitors Capacity Market Share of Key Manufacturers, 2020-2022
Table 123. Global PDE Inhibitors Production by Region, 2017-2022 (K Units)
Table 124. Global PDE Inhibitors Production by Region, 2023-2028 (K Units)
Table 125. PDE Inhibitors Market Opportunities & Trends in Global Market
Table 126. PDE Inhibitors Market Drivers in Global Market
Table 127. PDE Inhibitors Market Restraints in Global Market
Table 128. PDE Inhibitors Raw Materials
Table 129. PDE Inhibitors Raw Materials Suppliers in Global Market
Table 130. Typical PDE Inhibitors Downstream
Table 131. PDE Inhibitors Downstream Clients in Global Market
Table 132. PDE Inhibitors Distributors and Sales Agents in Global Market
LIST OF FIGURES
Figure 1. PDE Inhibitors Segment by Type
Figure 2. PDE Inhibitors Segment by Application
Figure 3. Global PDE Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PDE Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PDE Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. PDE Inhibitors Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PDE Inhibitors Revenue in 2021
Figure 9. By Type - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global PDE Inhibitors Price (USD/Unit), 2017-2028
Figure 12. By Application - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global PDE Inhibitors Price (USD/Unit), 2017-2028
Figure 15. By Region - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America PDE Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America PDE Inhibitors Sales Market Share, 2017-2028
Figure 19. US PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PDE Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PDE Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PDE Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PDE Inhibitors Sales Market Share, 2017-2028
Figure 33. China PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PDE Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America PDE Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PDE Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PDE Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global PDE Inhibitors Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production PDE Inhibitors by Region, 2021 VS 2028
Figure 50. PDE Inhibitors Industry Value Chain
Figure 51. Marketing Channels
Figure 1. PDE Inhibitors Segment by Type
Figure 2. PDE Inhibitors Segment by Application
Figure 3. Global PDE Inhibitors Market Overview: 2021
Figure 4. Key Caveats
Figure 5. Global PDE Inhibitors Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global PDE Inhibitors Revenue, 2017-2028 (US$, Mn)
Figure 7. PDE Inhibitors Sales in Global Market: 2017-2028 (K Units)
Figure 8. The Top 3 and 5 Players Market Share by PDE Inhibitors Revenue in 2021
Figure 9. By Type - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 10. By Type - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 11. By Type - Global PDE Inhibitors Price (USD/Unit), 2017-2028
Figure 12. By Application - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 13. By Application - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 14. By Application - Global PDE Inhibitors Price (USD/Unit), 2017-2028
Figure 15. By Region - Global PDE Inhibitors Sales Market Share, 2017-2028
Figure 16. By Region - Global PDE Inhibitors Revenue Market Share, 2017-2028
Figure 17. By Country - North America PDE Inhibitors Revenue Market Share, 2017-2028
Figure 18. By Country - North America PDE Inhibitors Sales Market Share, 2017-2028
Figure 19. US PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 20. Canada PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 21. Mexico PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 22. By Country - Europe PDE Inhibitors Revenue Market Share, 2017-2028
Figure 23. By Country - Europe PDE Inhibitors Sales Market Share, 2017-2028
Figure 24. Germany PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 25. France PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 26. U.K. PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 27. Italy PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 28. Russia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 29. Nordic Countries PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 30. Benelux PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 31. By Region - Asia PDE Inhibitors Revenue Market Share, 2017-2028
Figure 32. By Region - Asia PDE Inhibitors Sales Market Share, 2017-2028
Figure 33. China PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 34. Japan PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 35. South Korea PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 36. Southeast Asia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 37. India PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 38. By Country - South America PDE Inhibitors Revenue Market Share, 2017-2028
Figure 39. By Country - South America PDE Inhibitors Sales Market Share, 2017-2028
Figure 40. Brazil PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 41. Argentina PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 42. By Country - Middle East & Africa PDE Inhibitors Revenue Market Share, 2017-2028
Figure 43. By Country - Middle East & Africa PDE Inhibitors Sales Market Share, 2017-2028
Figure 44. Turkey PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 45. Israel PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 46. Saudi Arabia PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 47. UAE PDE Inhibitors Revenue, (US$, Mn), 2017-2028
Figure 48. Global PDE Inhibitors Production Capacity (K Units), 2017-2028
Figure 49. The Percentage of Production PDE Inhibitors by Region, 2021 VS 2028
Figure 50. PDE Inhibitors Industry Value Chain
Figure 51. Marketing Channels
